Regulations.gov document
Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions…
Other · FDA-2020-D-1136 · posted Sep 8, 2021
Key facts
| Document ID | FDA-2020-D-1136-0074 |
|---|---|
| Title | Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers; Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2020-D-1136 |
| Posted | Sep 8, 2021 |
| Comment period opens | Sep 8, 2021 |
| Comments due | May 12, 2023 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: